(Q39568910)

13 September 2017

title

Downregulation of zinc finger protein 132 in prostate cancer is associated with aberrant promoter hypermethylation and poor prognosis (English)

1 reference

Karina Dalsgaard Sørensen

13 September 2017

1 reference

10

0 references

12

0 references

Niels Tørring

5

0 references

author name string

Mette Opstrup Abildgaard

1

1 reference

13 September 2017

Michael Borre

2

1 reference

13 September 2017

Martin Mørck Mortensen

3

1 reference

13 September 2017

Benedicte P Ulhøi

4

1 reference

13 September 2017

Peter Wild

6

1 reference

13 September 2017

Helle Kristensen

7

1 reference

13 September 2017

Francisco Mansilla

8

1 reference

13 September 2017

Peter D Ottosen

9

1 reference

13 September 2017

Torben F Ørntoft

11

1 reference

13 September 2017

language of work or name

English

0 references

publication date

25 May 2011

1 reference

International Journal of Cancer

13 September 2017

published in

1 reference

13 September 2017

volume

130

1 reference

13 September 2017

issue

4

1 reference

13 September 2017

page(s)

885-895

1 reference

Estimates of the cancer incidence and mortality in Europe in 2006.

13 September 2017

cites work

1 reference

21 January 2018

Cancer statistics, 2009

1 reference

Mortality results from a randomized prostate-cancer screening trial

21 January 2018

1 reference

Screening and prostate-cancer mortality in a randomized European study

21 January 2018

1 reference

20-year outcomes following conservative management of clinically localized prostate cancer

21 January 2018

1 reference

Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial

21 January 2018

1 reference

Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results

21 January 2018

1 reference

Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis

21 January 2018

1 reference

The epigenomics of cancer

21 January 2018

1 reference

Abnormal DNA methylation, epigenetics, and prostate cancer

21 January 2018

1 reference

Hypermethylation of CpG islands in primary and metastatic human prostate cancer.

21 January 2018

1 reference

Isolation and fine mapping of 16 novel human zinc finger-encoding cDNAs identify putative candidate genes for developmental and malignant disorders

21 January 2018

1 reference

Keep your fingers off my DNA: protein-protein interactions mediated by C2H2 zinc finger domains

21 January 2018

1 reference

Genetic and epigenetic SLC18A2 silencing in prostate cancer is an independent adverse predictor of biochemical recurrence after radical prostatectomy

21 January 2018

1 reference

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

21 January 2018

1 reference

The natural history of prostate carcinoma based on a Danish population treated with no intent to cure

21 January 2018

1 reference

Promoter hypomethylation and upregulation of trefoil factors in prostate cancer.

21 January 2018

1 reference

The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.

21 January 2018

1 reference

Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy.

21 January 2018

1 reference

Aberrant epigenetic silencing is triggered by a transient reduction in gene expression

21 January 2018

1 reference

Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line

21 January 2018

1 reference

Dnmt3a-dependent nonpromoter DNA methylation facilitates transcription of neurogenic genes

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.26097

1 reference

13 September 2017

1 reference